. OpiantPharma to Develop sanofis Acute Cannabinoid Overdose Candidate Drinabant httpow.lyxHqn30n7a35Âpic.twitter.com1wppEgBpdG
. @Opiant_Pharma to Develop @sanofi’s Acute Cannabinoid #Overdose Candidate Drinabant: http://ow.ly/xHqn30n7a35 pic.twitter.com/1wppEgBpdG
More From BioPortfolio on ". @Opiant_Pharma to Develop @sanofi’s Acute Cannabinoid #Overdose Candidate Drinabant: http://ow.ly/xHqn30n7a35 pic.twitter.com/1wppEgBpdG"